Views: 0 Author: Denise Ho Publish Time: 2023-08-04 Origin: Site
On the momentous date of July 25, 2023, the AACC Annual Scientific Meeting & Clinical Lab Expo commenced with grandeur, capturing the essence of scientific innovation in the local time.
The AACC, inaugurated in 1949, has blossomed into the preeminent annual event in the global clinical laboratory domain, presenting an extensive array of cutting-edge clinical laboratory testing technology and in vitro diagnostic products each year. This global showcase exerts substantial international influence, drawing over 20,000 professionals from the laboratory sector and hosting more than 800 exhibitors from 110 countries and regions who unveiled their latest innovations.
In this distinguished gathering, RainSure marked its inaugural presence, unveiling a triumvirate of groundbreaking technologies – the DropDx-2044 digital PCR system, NanoGenerator™ nano-particle synthesis system, and the Fast-16 portable real-time fluorescence quantitative PCR instrument. This dynamic display captivated the attention of global distributors, laboratory users, and discerning professionals who visited, inquired, and engaged in negotiations. RainSure's proficient team warmly extended detailed explanations and comprehensive product introductions to each esteemed visitor, sharing pertinent solutions for digital PCR, and fostering robust collaborations with global partners.
As RainSure forges ahead, the company is poised to actively position itself in the overseas market, meticulously understanding the intricacies of international demands and steadfastly upgrading its products based on these insights, thereby elevating its global competitiveness.
RainSure stands as a beacon of innovation in the biotechnology landscape, dedicated to technological breakthroughs in the life sciences. Embracing the principles of innovation, intelligent manufacturing, and the pursuit of health, RainSure relies on avant-garde microfluidic technology, advanced optical platforms, and software systems to construct a leading molecular diagnostic platform.
The founding luminaries of RainSure are Ph.D. graduates from Ivy League institutions in the United States, endowed with robust academic backgrounds and a wealth of industrial experience. The core team has previously held positions in renowned biotechnology companies, contributing significantly to the development of several distinguished products. Since its inception, RainSure has garnered substantial investments, totalling nearly a hundred million yuan, from esteemed domestic institutions such as ZhenFund, Volcanics Capital, Mingshi Capital, Yuansheng Chuangtou, and QianDao Fund.
Remaining steadfast in its commitment to innovation, RainSure has successfully launched a myriad of products, including the heralded DropX series digital PCR system, over 100 RUO test reagent kits, and nano-particle synthesis systems. RainSure's digital PCR system boasts the prestigious NMPA, FDA-EUA, and CE-IVD medical certifications, distinguishing it as the sole recipient of such accolades in the digital PCR system domain. With a design characterized by high automation and integration, it significantly economizes on labour costs and minimizes subjective operational errors. The platform is also compatible with third-party qPCR reagents, allowing for the storage of rare samples post-detection and ensuring traceability of results. RainSure's innovations have received widespread acclaim from hospitals, pharmaceutical companies, and research users in China. The company maintains stringent quality control standards across all facets of product development, demonstrating an unwavering commitment to providing high-quality, high-performance products for its esteemed clientele.
